Kenvue Inc. Common Stock vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Direxion Daily TSLA Bull 2X Shares trades at $10.41 (market cap $3.97B). The key difference: Kenvue Inc. Common Stock is far larger — about 8.6× Direxion Daily TSLA Bull 2X Shares's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Direxion Daily TSLA Bull 2X Shares pays none. Which is the better fit depends on your goals.
| KVUE | TSLL | |
|---|---|---|
Market Cap | $34.06B | $3.97B |
Volume | 23,267,228 | 38,458,237 |
Sector | Consumer Staples | Leveraged / Inverse |
52-Week High | $19.83 | $23.03 |
52-Week Low | $14.11 | $6.74 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 15 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TSLL, the Direxion Daily TSLA Bull 2X Shares ETF, trades at $10.40, up 2.46% today, with a neutral technical signal overall but bullish moving averages. As a leveraged ETF tracking Tesla, its performance is tied to daily Tesla stock movements, amplified by 2x. Recent news highlights its volatility, with a rally noted ahead of Tesla's Cybercab event. Key support and resistance levels are clustered around $10, with RSI_6 indicating potential overbought conditions.
The outlook for TSLL is highly speculative, offering amplified exposure to Tesla's stock swings, which can lead to significant gains or losses. Investment opportunities exist for short-term traders betting on Tesla's momentum, but risks include daily reset mechanics causing decay in volatile markets and dependence on Tesla's performance. Long-term holding is discouraged due to structural risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →